Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed adults with HIV infection and osteopenia
2014-002720-27Phase 4Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of atazanavir, ritonavir and lamivudine in human immunodeficiency virus infection (HIV), sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Change in bone mineral density. Started Nov 2014; status: completed.
02
Drugs
atazanavirritonavirlamivudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2014-002720-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002720-27.